Entries by Melissa Gillespie

Drug Information Association Meeting

Welocalize Life Sciences will exhibit at the annual Drug Information Association (DIA) Meeting in Chicago, IL, June 18-22, 2017. Key stakeholders will come together to discuss the most important challenges in healthcare product development in one place and platform: the DIA 2017 Annual Meeting. Welocalize Life Sciences is dedicated to the highly regulated industries of […]

Summit for Clinical Ops Executives

Welocalize Life Sciences is an exhibitor at booth #517 at the 8th Annual Summit for Clinical Ops Executives (SCOPE), January 24-26, in Miami, FL.  SCOPE brings together over 1,500 clinical operations thought leaders and innovators for three-days of workshops, discussions and exhibits related to each aspect of clinical trial planning and management, including site selection, recruitment […]

Welocalize Life Sciences Exhibits at SCOPE 2017

Frederick, Maryland – January 23, 2017 –Welocalize Life Sciences, a leader in specialized language services for life sciences and regulated industries, is an exhibitor at booth #517 at the 8th Annual Summit for Clinical Ops Executives (SCOPE), January 24-26, in Miami, FL.  SCOPE brings together over 1,500 clinical operations thought leaders and innovators for three-days of […]

One-third of Hospitals in U.S. Fail to Offer Language Services

Twenty-four million people in the United States have limited English proficiency. They experience barriers to health care because of their inability to communicate effectively with providers.According to an analysis published recently in Health Affairs, more than a third of the hospitals in the United States in 2013 did not offer patients access to language assistance. […]

Why Racial Diversity in Clinical Trials Matters

Clinical trials provide a critical base of evidence for evaluating whether a medical product is effective before the product is approved for marketing. One challenge that remains is ensuring that research participants are representative of the patients who will use the medical product.In 2014, the Federal Drug Administration (FDA) released a report that called for, […]